3 ms·
> So where am I wrong? Where you think processing the data just means loading up an excel table (or running a CSV through R) and that's the only data relating
by raverbashing 6y ago
> So where am I wrong?
Where you think processing the data just means loading up an excel table (or running a CSV through R) and that's the only data relating to the studies. Patient data is not the only thing being analyzed and it includes things like manufacturing, transport, etc
> Where is this MD, MPH from Johns Hopkins wrong?
He's not wrong but his worries as a clinical trial expert are a subset of the worries of an agency like the FDA. And I'm sure his workflow as clinical study expert is more fine tuned for that.
Or as in a developer analogy: making a code change is a 5 minute job. Actually making the change, testing, deploying, etc may take a whole day.
> Why is the UK able to approve it over a week ago but the FDA needs longer?
Pfizer sent the last info to the FDA on 22th of November. The MHRA had started a rolling review and received the last batch of info they needed on the 23rd of November.
I am certainly frustrated with the speed as well, but I don't think it's too much of a difference. Yes, maybe it could be faster.
- creddit 6y ago> Where you think processing the data just means loading up an excel table (or running a CSV through R) Is it possible you could construct an even more ridiculous straw man? > I am certainly frustrated with the speed as well... Yes, maybe it could be faster. Oh, so you agree with what I'm saying and your problem is the straw man argument you created.